Description
Elipta 5/10 mg is a dual-action dry powder inhaler formulated for the long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) and asthma. It combines two powerful bronchodilators – a Long-Acting Muscarinic Antagonist (LAMA) and a Long-Acting Beta2 Agonist (LABA) – providing 24-hour relief from airway obstruction and improving breathing comfort and lung function.
.webp)
Change Language